ESG Genexine's today makes a sustainable tomorrow

Genexine is actively changing the times by introducing ESG (Environmental · Social Value · Governance) management to existing management principles “TIPS.“ This is for sustainable management and a sustainable world in which future generations will live. Genexine develops innovative treatments to save the lives of many patients and improve their quality of life.




We remain aware and caring toward the environment in which we live and strive to maximize our beneficial impact towards the patient while minimizing any potential unwanted impact we may have.


To fulfill its corporate social responsibility, Genexine not only contributes to the healthy life of humanity through the research and development of novel new drugs but also strives for sustainable partnerships with partner companies. To achieve healthcare value creation, we not only inspect quality and safety at a high level of responsibility but also respect the human rights of all stakeholders, including executives and employees.


Genexine has established an international Board of Directors that ensures all measures of good corporate governance are followed. Genexine has set up hotline support and has implemented a robust whistle-blower policy to ensure ethical guidelines are adhered to.